Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam in intracranial aneurysm interventional embolization
ChiCTR2100041808Phase 4Recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in brain aneurysm (IA) (3 arms), sponsored by Shanxi Bethune Hospital. Primary endpoints: blood pressure, heart rate and 1 more. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ChiCTR2100041808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041808.